IME MEDICAL ELECTROSPINNING

IME Medical Electrospinning appoints Sander de Vos as Chief Business Officer

Retrieved on:

Thursday, April 1, 2021

Given names, Nanotechnology, Spinning, Electrospinning, Ime, De Vos, Vos, Sander

WAALRE,Netherlands, April 1, 2021 /PRNewswire/ -- IME Medical Electrospinning, a global leader in electrospun medical devices for tissue rebuilding and regenerative medicine as well as implants and drug delivery solutions,today announced that it has further strengthened its management team with the appointment ofSander de Vos as Chief Business Officer (CBO).

Key Points:

WAALRE,Netherlands, April 1, 2021 /PRNewswire/ -- IME Medical Electrospinning, a global leader in electrospun medical devices for tissue rebuilding and regenerative medicine as well as implants and drug delivery solutions,today announced that it has further strengthened its management team with the appointment ofSander de Vos as Chief Business Officer (CBO).
He will be responsible for the worldwide roll-out of the company's medical electrospinning strategy, based on IME's ground-breaking MediSpinXL industrial production platform.
Judith Heikoop, CEO of IME Medical Electrospinning comments:
"We at IME are thrilled to welcome Sander to our fast-growing team of professionals.
Sander de Vos (46) is an accomplished executive with more than 15 years of leadership experience across healthcare and biotech commercial and business development positions.

IME Medical Electrospinning appoints Sander de Vos as Chief Business Officer

Retrieved on:

Thursday, April 1, 2021

Given names, Nanotechnology, Spinning, Electrospinning, Ime, De Vos, Vos, Sander

WAALRE,Netherlands, April 1, 2021 /PRNewswire/ -- IME Medical Electrospinning, a global leader in electrospun medical devices for tissue rebuilding and regenerative medicine as well as implants and drug delivery solutions,today announced that it has further strengthened its management team with the appointment ofSander de Vos as Chief Business Officer (CBO).

Key Points:

WAALRE,Netherlands, April 1, 2021 /PRNewswire/ -- IME Medical Electrospinning, a global leader in electrospun medical devices for tissue rebuilding and regenerative medicine as well as implants and drug delivery solutions,today announced that it has further strengthened its management team with the appointment ofSander de Vos as Chief Business Officer (CBO).
He will be responsible for the worldwide roll-out of the company's medical electrospinning strategy, based on IME's ground-breaking MediSpinXL industrial production platform.
Judith Heikoop, CEO of IME Medical Electrospinning comments:
"We at IME are thrilled to welcome Sander to our fast-growing team of professionals.
Sander de Vos (46) is an accomplished executive with more than 15 years of leadership experience across healthcare and biotech commercial and business development positions.

IME Medical Electrospinning and STENTiT enter into development cooperation on resorbable endovascular support grafts to regenerate vascular tissue

Retrieved on:

Wednesday, February 10, 2021

Medical technology, Interventional radiology, Medicine, Electrospinning, Nanotechnology, Spinning, Medical device, Stent, Implant, Technology

STENTiT is an emerging player in the field of regenerative medical devices, offering a breakthrough solution for cardiovascular interventions developing first-of-its-kind regenerative endovascular blood vessel implants.

Key Points:

STENTiT is an emerging player in the field of regenerative medical devices, offering a breakthrough solution for cardiovascular interventions developing first-of-its-kind regenerative endovascular blood vessel implants.
"We are thrilled to join forces with IME Medical Electrospinning to further optimize our fibrillated endovascular implants.
IME Medical Electrospinning develops medical devices in close collaboration with an ever-growing portfolio of customers and partners worldwide within the industry, the scientific environment, hospitals and medical institutes.
STENTiT is a medical device spin-off company from Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants.

IME Medical Electrospinning and STENTiT enter into development cooperation on resorbable endovascular support grafts to regenerate vascular tissue

Retrieved on:

Wednesday, February 10, 2021

Medical technology, Interventional radiology, Medicine, Electrospinning, Nanotechnology, Spinning, Medical device, Stent, Implant, Technology

STENTiT is an emerging player in the field of regenerative medical devices, offering a breakthrough solution for cardiovascular interventions developing first-of-its-kind regenerative endovascular blood vessel implants.

Key Points:

STENTiT is an emerging player in the field of regenerative medical devices, offering a breakthrough solution for cardiovascular interventions developing first-of-its-kind regenerative endovascular blood vessel implants.
"We are thrilled to join forces with IME Medical Electrospinning to further optimize our fibrillated endovascular implants.
IME Medical Electrospinning develops medical devices in close collaboration with an ever-growing portfolio of customers and partners worldwide within the industry, the scientific environment, hospitals and medical institutes.
STENTiT is a medical device spin-off company from Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants.

IME Medical Electrospinning secured € 3 million in new financing from Dutch VCs Borski Fund, Lumana Invest, TIIN Capital and from Rabobank to further expand its Medispin XL production platform

Retrieved on:

Thursday, September 3, 2020

Nanotechnology, Electrospinning, Articles, Medical devices, Stent, Spinning

To be able to manage the electrospinning control parameters unlocks its full potential for industrial medical applications.

Key Points:

To be able to manage the electrospinning control parameters unlocks its full potential for industrial medical applications.
Human cells recognize and infiltrate these scaffolds, encouraging quick and efficient tissue integration, resulting in natural tissue restoration while minimizing medical complications.
The vast array of innovative applications include fully bioresorbable stents, heart valves, nanofibrous meshes and many other new devices for a.o.
Electrospinning is a flexible process for producing extremely thin fibers and structures that have excellent properties to help regenerate human tissue.

IME Medical Electrospinning secured € 3 million in new financing from Dutch VCs Borski Fund, Lumana Invest, TIIN Capital and from Rabobank to further expand its Medispin XL production platform

Retrieved on:

Thursday, September 3, 2020

Nanotechnology, Electrospinning, Articles, Medical devices, Stent, Spinning

To be able to manage the electrospinning control parameters unlocks its full potential for industrial medical applications.

Key Points:

To be able to manage the electrospinning control parameters unlocks its full potential for industrial medical applications.
Human cells recognize and infiltrate these scaffolds, encouraging quick and efficient tissue integration, resulting in natural tissue restoration while minimizing medical complications.
The vast array of innovative applications include fully bioresorbable stents, heart valves, nanofibrous meshes and many other new devices for a.o.
Electrospinning is a flexible process for producing extremely thin fibers and structures that have excellent properties to help regenerate human tissue.